The 20 Best Adult Soft Tissue Sarcoma Doctors in District of Columbia, US

Jeffrey Toretsky is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Toretsky is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Bone Marrow Aspiration.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, and Prostatectomy.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Glioma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, Gastrointestinal Stromal Tumor, and Prostatectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Matthew Ladra, M.D., M.P.H., leads the dedicated pediatric team for the Johns Hopkins Proton Therapy Center and is the director of pediatric radiation oncology for the Johns Hopkins Kimmel Cancer Center, a clinical collaboration with Children’s National Hospital, where Dr. Ladra serves as faculty in the department of pediatric oncology. He is also an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine. Listen Dr. Ladra's Cancer Matters podcast episode to learn more about his work. Previously, Dr. Ladra served as the director of pediatric radiation at the Provision Center for Proton Therapy in Tennessee. He also completed a 2-year fellowship in pediatric proton therapy at the Massachusetts General Hospital’s Francis H. Burr Proton Center. Dr. Ladra is one of a handful of radiation oncologists whose research and clinical efforts focus exclusively on pediatric patients. He is frequently invited to speak on pediatric radiation oncology topics internationally and across the U.S. and has published extensively on the subject through original research book chapters and review articles. Dr. Ladra’s research efforts focus mainly on pediatric rhabdomyosarcoma treatment, early phase clinical trials involving radiation and non-chemotherapeutic agents, and reducing neurocognitive toxicity for pediatric brain tumor patients. LinkedIn https://www.linkedin.com/in/matthew-ladra-3094a316. Dr. Ladra is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Rhabdomyosarcoma, Muscle Invasive Bladder Cancer, Ependymoma, and Adult Soft Tissue Sarcoma.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Dennis Priebat is a Hematologist in Washington, Washington, D.c.. Dr. Priebat is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Rhabdomyosarcoma Embryonal.

Robert Henshaw is an Orthopedics provider in Washington, Washington, D.c.. Dr. Henshaw is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Bone Tumor, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, Osteotomy, and Bone Graft.

Keith Unger is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Unger is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Anal Cancer, and Adult Soft Tissue Sarcoma.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Mary Wilkinson is a medical oncologist caring for patients with breast cancer and gyn malignancies. Dr. Wilkinson sees patients primarily at Sibley Memorial Hospital in Washington DC. She also serves as clinical director of the Under Armour Breast Health Innovation Center at the Sidney Kimmel Comprehensive Cancer Center. Dr. Wilkinson received her undergraduate degree in electrical engineering from Rice University and earned her M.D. from Stanford University School of Medicine. She completed her residency and performed a fellowship in hematology and oncology at the University of California, San Francisco. Dr. Wilkinson joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Wilkinson was director of breast cancer research at the Inova Schar Cancer Institute and president of Medical Oncology Hematology Associates of Northern Virginia. She also spent time on the faculty at Georgetown University and the University of California, San Francisco. Dr. Wilkinson is a member of the American Society of Clinical Oncology. Dr. Wilkinson is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Pancreaticoduodenectomy, and Gastrostomy.

Dr. Mildred R. Chernofsky is a gynecologic oncologist at Sibley Memorial Hospital and an associate professor in obstetrics and gynecology at George Washington University School of Medicine and the Uniformed Services University of the Health Sciences (USUHS). She practices out of the Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery. Dr. Chernofsky is affiliated with Sibley Memorial Hospital and George Washington University Hospital. With a focus on gynecology and obstetrics, Dr. Chernofsky has an expertise in advanced laparoscopy, gestational trophoblastic disease and robotic surgery. Dr. Chernofsky earned her medical degree from Pennsylvania State University College of Medicine. She completed a general internship and a residency in obstetrics and gynecology at the National Naval Medical Center of San Diego, as well as a fellowship in gynecologic oncology at the Los Angeles County/University of Southern California Medical Center. Dr. Chernofsky was named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly in 2012 and 2014. She was also named a Top Doctor in the D.C. region by Washingtonian Magazine. Dr. Chernofsky is also a fellow of the American Congress of Obstetricians and Gynecologists. Dr. Chernofsky has clinical interests in uterine, ovarian, cervical and vulvar cancers, as well as genital dysplasia. She has contributed to numerous clinical trials in her position as a principal investigator for Gynecologic Oncology Group (GOG), as well as various publications and presentations. Dr. Chernofsky also participates in patient educational forums both locally and those sponsored by the Foundation for Women’s Cancer. Dr. Chernofsky is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Hysterectomy.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Breast Cancer, and Familial Pancreatic Cancer.

Michael Atkins is an Oncologist in Washington, Washington, D.c.. Dr. Atkins is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Nephrectomy.

Peter Ahn is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Ahn is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Throat Cancer, and Acinic Cell Carcinoma of Salivary Glands.

Suthee Rapisuwon is a Hematologist in Washington, Washington, D.c.. Dr. Rapisuwon is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Renal Cell Carcinoma (RCC).

Adedamola Omogbehin is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Omogbehin is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Adenoid Cystic Carcinoma, Anal Cancer, Endometrial Cancer, and Intraductal Papilloma.